Conversely, a study in men with obesity and metabolic syndrome showed decreased peripheral insulin sensitivity after seven days of vancomycin treatment, although effects were small and this study did not include a control group.17 Thus, the sparse evidence on the effect of vancomycin use on metabolic health is contradictory. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.